Esperion Therapeutics Downgraded On Regulatory Concerns By Credit Suisse
June 29, 2016 at 09:44 AM EDT
Credit Suisse’s Vamil Divan expressed concern regarding the outlook for bempedoic acid in the U.S. market, following the update ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.